155 related articles for article (PubMed ID: 34647152)
1. The intestinal flora of patients with GHPA affects the growth and the expression of PD-L1 of tumor.
Nie D; Fang Q; Cheng J; Li B; Li M; Wang H; Li C; Gui S; Zhang Y; Zhao P
Cancer Immunol Immunother; 2022 May; 71(5):1233-1245. PubMed ID: 34647152
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of Gut Microbiota in Patients with GH-Secreting Pituitary Adenoma.
Lin B; Wang M; Gao R; Ye Z; Yu Y; He W; Qiao N; Ma Z; Ji C; Shi C; Zhou X; Wang Y; Zeng F; Zhang L; Gong W; Cao Z; Zhou P; Melnikov V; Ye H; Li Y; Zhang Z; He M; Qin H; Zhang Y
Microbiol Spectr; 2022 Feb; 10(1):e0042521. PubMed ID: 35019688
[TBL] [Abstract][Full Text] [Related]
3. BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma.
Shi C; Ye Z; Han J; Ye X; Lu W; Ji C; Li Z; Ma Z; Zhang Q; Zhang Y; He W; Chen Z; Cao X; Shou X; Zhou X; Wang Y; Zhang Z; Li Y; Ye H; He M; Chen H; Cheng H; Sun J; Cai J; Huang C; Ye F; Luo C; Zhou B; Ding H; Zhao Y
Neuro Oncol; 2020 Aug; 22(8):1114-1125. PubMed ID: 32246150
[TBL] [Abstract][Full Text] [Related]
4. Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma.
Tucker DW; Pangal DJ; Du R; Gogia AS; Tafreshi A; Ruzevick J; Hurth KT; Triche T; Micko A; Carpten JD; Shiroishi MS; Carmichael JD; Rhie SK; Zada G
PLoS One; 2023; 18(4):e0284949. PubMed ID: 37104368
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Cyclooxygenase 2, Programmed Cell Death Ligand 1, and Arginase 1 Expression in Human Pituitary Adenoma.
Zhao G; Chen W; He J; Cui C; Zhao L; Zhao Y; Sun C; Nie D; Jin F; Kong L
World Neurosurg; 2020 Dec; 144():e660-e673. PubMed ID: 32920160
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive circular RNA profiling reveals that hsa_circ_0001368 is involved in growth hormone-secreting pituitary adenoma development.
Du Q; Zhang W; Feng Q; Hao B; Cheng C; Cheng Y; Li Y; Fan X; Chen Z
Brain Res Bull; 2020 Aug; 161():65-77. PubMed ID: 32389802
[TBL] [Abstract][Full Text] [Related]
7. The p300 Inhibitor A-485 Exerts Antitumor Activity in Growth Hormone Pituitary Adenoma.
Ji C; Xu W; Ding H; Chen Z; Shi C; Han J; Yu L; Qiao N; Zhang Y; Cao X; Zhou X; Cheng H; Feng H; Luo C; Li Z; Zhou B; Ye Z; Zhao Y
J Clin Endocrinol Metab; 2022 May; 107(6):e2291-e2300. PubMed ID: 35247260
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor GTF2B regulates AIP protein expression in growth hormone-secreting pituitary adenomas and influences tumor phenotypes.
Cai F; Chen S; Yu X; Zhang J; Liang W; Zhang Y; Chen Y; Chen S; Hong Y; Yan W; Wang W; Zhang J; Wu Q
Neuro Oncol; 2022 Jun; 24(6):925-935. PubMed ID: 34932801
[TBL] [Abstract][Full Text] [Related]
9. Role of EGFL7/EGFR-signaling pathway in migration and invasion of growth hormone-producing pituitary adenomas.
Liu Q; Zhang J; Gao H; Yuan T; Kang J; Jin L; Gui S; Zhang Y
Sci China Life Sci; 2018 Aug; 61(8):893-901. PubMed ID: 29951953
[TBL] [Abstract][Full Text] [Related]
10. Global changes in chromatin accessibility and transcription in growth hormone-secreting pituitary adenoma.
Wang M; Ji C; Zhang Y; Zhang Z; Zhang Y; Guo H; Qiao N; Zhou X; Cao X; Ye Z; Yu Y; Melnikov V; Gong W; He M; Zhang Z; Zhao Y; Wang X; Wei G; Ye Z
Endocrine; 2022 Nov; 78(2):329-342. PubMed ID: 35947334
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors.
Mei Y; Bi WL; Greenwald NF; Du Z; Agar NY; Kaiser UB; Woodmansee WW; Reardon DA; Freeman GJ; Fecci PE; Laws ER; Santagata S; Dunn GP; Dunn IF
Oncotarget; 2016 Nov; 7(47):76565-76576. PubMed ID: 27655724
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiome-derived butyrate inhibits the immunosuppressive factors PD-L1 and IL-10 in tumor-associated macrophages in gastric cancer.
Lee SY; Jhun J; Woo JS; Lee KH; Hwang SH; Moon J; Park G; Choi SS; Kim SJ; Jung YJ; Song KY; Cho ML
Gut Microbes; 2024; 16(1):2300846. PubMed ID: 38197259
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone secreting pituitary adenomas show distinct extrasellar extension patterns compared to nonfunctional pituitary adenomas.
Pangal DJ; Wishart D; Shiroishi MS; Ruzevick J; Carmichael JD; Zada G
Pituitary; 2022 Jun; 25(3):480-485. PubMed ID: 35334028
[TBL] [Abstract][Full Text] [Related]
14. Exosomal hsa-miR-21-5p derived from growth hormone-secreting pituitary adenoma promotes abnormal bone formation in acromegaly.
Xiong Y; Tang Y; Fan F; Zeng Y; Li C; Zhou G; Hu Z; Zhang L; Liu Z
Transl Res; 2020 Jan; 215():1-16. PubMed ID: 31469974
[TBL] [Abstract][Full Text] [Related]
15. Effects of PD-1/PD-L1 signaling pathway on intestinal flora in patients with colorectal cancer.
Pi H; Huang L; Liu H; Liang S; Mei J
Cancer Biomark; 2020; 28(4):529-535. PubMed ID: 32568184
[TBL] [Abstract][Full Text] [Related]
16. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
17. Central Hypothyroidism Related to Pituitary Adenomas: Low Incidence of Central Hypothyroidism in Patients With Acromegaly.
Takamizawa T; Horiguchi K; Nakajima Y; Okamura T; Ishida E; Matsumoto S; Yoshino S; Yamada E; Saitoh T; Ozawa A; Tosaka M; Yamada S; Yamada M
J Clin Endocrinol Metab; 2019 Oct; 104(10):4879-4888. PubMed ID: 31188431
[TBL] [Abstract][Full Text] [Related]
18. MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes.
Uraki S; Ariyasu H; Doi A; Takeshima K; Morita S; Inaba H; Furuta H; Fukuhara N; Inoshita N; Nishioka H; Nakao N; Yamada S; Akamizu T
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325698
[TBL] [Abstract][Full Text] [Related]
19. The role of intestinal flora on tumorigenesis, progression, and the efficacy of PD-1/PD-L1 antibodies in colorectal cancer.
Wang S; Xu B; Zhang Y; Chen G; Zhao P; Gao Q; Yuan L
Cancer Biol Med; 2023 Dec; 21(1):65-82. PubMed ID: 38148328
[TBL] [Abstract][Full Text] [Related]
20. Establishment of humanized tumor microenvironment mouse models based on the injection of peripheral blood mononuclear cells and IFN-γ to evaluate the efficacy of PD-L1/PD-1-targeted immunotherapy.
Lin X; Zeng T; Lin J; Zhang Q; Cheng H; Fang S; Lin S; Chen Y; Xu Y; Lin J
Cancer Biol Ther; 2020; 21(2):130-138. PubMed ID: 31690181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
